Total raised
—
Last: Undisclosed 2020-01
Stage
Seed
Founded
2019
Headcount
4
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Xinteza is developing advanced proprietary biosynthesis and bioextraction technologies related to the production of cannabinoid-based active pharmaceutical ingredients (APIs) for the pharmaceutical and food industries.
The company is engaged in the research and discovery of a wide array of new genes and ultra-novel genetic paths for the biosynthesis of cannabinoids and psychoactive ingredients and the development of their bioproduction methods. Xinteza holds the exclusive license for both cannabinoids and psychoactives from the Weizmann Institute and is building an exceptional portfolio of dozens of related IP and patents.
Funding history · 1 round · — total
2020-01
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsMoleculesGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
natural-active-ingredientsagtechmedical-cannabisplant-genomicsapicannabispharmaceuticals